RVTY
Get informed when a big investor buys or sells
+ FollowOvervalued by 35.7% based on the discounted cash flow analysis.
| Market cap | $12.79 Billion |
|---|---|
| Enterprise Value | $15.11 Billion |
| Dividend Yield | $0.28 (0.24%) |
| Earnings per Share | $2.08 |
| Beta | 1.09 |
| Outstanding Shares | 111,746,000 |
| P/E Ratio | 54.6 |
|---|---|
| PEG | -1384.19 |
| Price to Sales | 4.52 |
| Price to Book Ratio | 1.84 |
| Enterprise Value to Revenue | 5.19 |
| Enterprise Value to EBIT | 42.45 |
| Enterprise Value to Net Income | 63 |
| Total Debt to Enterprise | 0.22 |
| Debt to Equity | 0.46 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.5000▼ 1149.38% |
|---|---|
| Total Calls | 1,800▼ 97.18% |
| Total Puts | 900▼ 99.88% |
Holdings and activity of institutional investors.
| Ownership % | 20.76%▼ 82.46% |
|---|---|
| Total Invested | $2.58B▼ 74.48% |
| Investors Holding | 280▼ 230.00% |
No data
PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to ser...